Cryo-Cell International, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-60.6% vs price
Base Case (Median)
-55.7% vs price
Bull Case (75th pct.)
114.8% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $1.74 | -55.7% | High (40%) |
| EV/EBITDA | $1.36 | -65.4% | Medium (20%) |
| EV/FCF | $15.14 | 285.3% | Medium (20%) |
Based on 3 out of 8 methods, CCEL appears fairly valued at the current price of $3.93. The base case fair value of $1.74 implies 55.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.